Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 103


Gender Disparity in Cystectomy Postoperative Outcomes: Propensity Score Analysis of the National Surgical Quality Improvement Program Database.

Bukavina L, Mishra K, Mahran A, Shekar A, Sheyn D, Slopnick E, Hijaz A, Jankowski J, Ponsky L, Nguyen C.

Eur Urol Oncol. 2019 Apr 26. pii: S2588-9311(19)30052-5. doi: 10.1016/j.euo.2019.04.004. [Epub ahead of print]


Kidney volume loss following percutaneous nephrolithotomy utilizing 3D planimetry.

Wang M, Bukavina L, Mishra K, Mahran A, Ponsky L, Gnessin E.

Urolithiasis. 2019 Jul 25. doi: 10.1007/s00240-019-01149-7. [Epub ahead of print]


MR Fingerprinting and ADC Mapping for Characterization of Lesions in the Transition Zone of the Prostate Gland.

Panda A, Obmann VC, Lo WC, Margevicius S, Jiang Y, Schluchter M, Patel IJ, Nakamoto D, Badve C, Griswold MA, Jaeger I, Ponsky LE, Gulani V.

Radiology. 2019 Sep;292(3):685-694. doi: 10.1148/radiol.2019181705. Epub 2019 Jul 23.


The Emerging Role of Stereotactic Ablative Radiotherapy for Primary Renal Cell Carcinoma: A Systematic Review and Meta-Analysis.

Correa RJM, Louie AV, Zaorsky NG, Lehrer EJ, Ellis R, Ponsky L, Kaplan I, Mahadevan A, Chu W, Swaminath A, Hannan R, Onishi H, Teh BS, Muacevic A, Lo SS, Staehler M, Siva S.

Eur Urol Focus. 2019 Jun 24. pii: S2405-4569(19)30157-9. doi: 10.1016/j.euf.2019.06.002. [Epub ahead of print] Review.


Comparison of 30-day postoperative outcomes of open and minimally invasive pyeloplasty utilizing the prospective National Surgical Quality Improvement Program-Pediatric database.

Woo K, Bukavina L, Mishra K, Mahran A, Prunty M, Ponsky L, DiCarlo H, Ross J, Woo L.

J Pediatr Urol. 2019 Aug;15(4):355.e1-355.e8. doi: 10.1016/j.jpurol.2019.05.022. Epub 2019 May 27.


Is there a benefit to additional neuroaxial anesthesia in open nephrectomy? A prospective NSQIP propensity score analysis.

Mahran A, Mishra K, Omil-Lima D, Abboud B, Wang M, Jankowski J, Abouassaly R, Ponsky L, Lengu I, Bukavina L.

Int Urol Nephrol. 2019 Sep;51(9):1481-1489. doi: 10.1007/s11255-019-02208-z. Epub 2019 Jun 20.


Observed racial disparity in the negative predictive value of multi-parametric MRI for the diagnosis for prostate cancer.

Mahran A, Mishra K, Bukavina L, Schumacher F, Quian A, Buzzy C, Nguyen CT, Gulani V, Ponsky LE.

Int Urol Nephrol. 2019 Aug;51(8):1343-1348. doi: 10.1007/s11255-019-02158-6. Epub 2019 May 2.


Targeted Biopsy Validation of Peripheral Zone Prostate Cancer Characterization With Magnetic Resonance Fingerprinting and Diffusion Mapping.

Panda A, OʼConnor G, Lo WC, Jiang Y, Margevicius S, Schluchter M, Ponsky LE, Gulani V.

Invest Radiol. 2019 Aug;54(8):485-493. doi: 10.1097/RLI.0000000000000569.


Mood outcomes of a behavioral treatment for urinary incontinence in prostate cancer survivors.

Zhang AY, Ganocy S, Fu AZ, Kresevic D, Ponsky L, Strauss G, Bodner DR, Zhu H.

Support Care Cancer. 2019 Mar 22. doi: 10.1007/s00520-019-04745-w. [Epub ahead of print]


Green tea-induced epigenetic reactivation of tissue inhibitor of matrix metalloproteinase-3 suppresses prostate cancer progression through histone-modifying enzymes.

Deb G, Shankar E, Thakur VS, Ponsky LE, Bodner DR, Fu P, Gupta S.

Mol Carcinog. 2019 Jul;58(7):1194-1207. doi: 10.1002/mc.23003. Epub 2019 Mar 10.


Stereotactic Radiotherapy as a Treatment Option for Renal Tumors in the Solitary Kidney: A Multicenter Analysis from the IROCK.

Correa RJM, Louie AV, Staehler M, Warner A, Gandhidasan S, Ponsky L, Ellis R, Kaplan I, Mahadevan A, Chu W, Swaminath A, Onishi H, Teh BS, Lo SS, Muacevic A, Siva S.

J Urol. 2019 Jun;201(6):1097-1104. doi: 10.1097/JU.0000000000000111.


Whole mount histopathological correlation with prostate MRI in Grade I and II prostatectomy patients.

Wang M, Janaki N, Buzzy C, Bukavina L, Mahran A, Mishra K, MacLennan G, Ponsky L.

Int Urol Nephrol. 2019 Mar;51(3):425-434. doi: 10.1007/s11255-019-02083-8. Epub 2019 Jan 22.


Bladder irrigation after transurethral resection of superficial bladder cancer: a systematic review of the literature.

Mahran A, Bukavina L, Mishra K, Buzzy C, Fish ML, Bobrow A, Ponsky L.

Can J Urol. 2018 Dec;25(6):9579-9584.


Variability in Prices for Erectile Dysfunction Medications-Are All Pharmacies the Same?

Mishra K, Bukavina L, Mahran A, Bobrow A, Buzzy CA, Jain N, Gnessin E, Loeb A, Ponsky LE.

J Sex Med. 2018 Dec;15(12):1785-1791. doi: 10.1016/j.jsxm.2018.10.011.


Diagnostic Accuracy of a Rapid Biparametric MRI Protocol for Detection of Histologically Proven Prostate Cancer.

Obmann VC, Pahwa S, Tabayayong W, Jiang Y, O'Connor G, Dastmalchian S, Lu J, Shah S, Herrmann KA, Paspulati R, MacLennan G, Ponsky L, Abouassaly R, Gulani V.

Urology. 2018 Dec;122:133-138. doi: 10.1016/j.urology.2018.08.032. Epub 2018 Sep 7.


Identifying the morphologic basis for radiomic features in distinguishing different Gleason grades of prostate cancer on MRI: Preliminary findings.

Penzias G, Singanamalli A, Elliott R, Gollamudi J, Shih N, Feldman M, Stricker PD, Delprado W, Tiwari S, Böhm M, Haynes AM, Ponsky L, Fu P, Tiwari P, Viswanath S, Madabhushi A.

PLoS One. 2018 Aug 31;13(8):e0200730. doi: 10.1371/journal.pone.0200730. eCollection 2018.


Younger Men With Prostate Cancer Have Lower Risk of Upgrading While on Active Surveillance: A Meta-analysis and Systematic Review of the Literature.

Mahran A, Turk A, Buzzy C, Wang M, Yang J, Neudecker M, Jaeger I, Ponsky LE.

Urology. 2018 Nov;121:11-18. doi: 10.1016/j.urology.2018.06.048. Epub 2018 Jul 26.


Patient Reported Outcomes in NRG Oncology RTOG 0938, Evaluating Two Ultrahypofractionated Regimens for Prostate Cancer.

Lukka HR, Pugh SL, Bruner DW, Bahary JP, Lawton CAF, Efstathiou JA, Kudchadker RJ, Ponsky LE, Seaward SA, Dayes IS, Gopaul DD, Michalski JM, Delouya G, Kaplan ID, Horwitz EM, Roach M 3rd, Pinover WH, Beyer DC, Amanie JO, Sandler HM, Kachnic LA.

Int J Radiat Oncol Biol Phys. 2018 Oct 1;102(2):287-295. doi: 10.1016/j.ijrobp.2018.06.008. Epub 2018 Jun 18.


Evaluating the impact of the genitourinary multidisciplinary tumour board: Should every cancer patient be discussed as standard of care?

Scarberry K, Ponsky L, Cherullo E, Larchian W, Bodner D, Cooney M, Ellis R, Maclennan G, Johnson B, Tabayoyong W, Abouassaly R.

Can Urol Assoc J. 2018 May 14. doi: 10.5489/cuaj.5150. [Epub ahead of print]


Comparative analysis for renal stereotactic body radiotherapy using Cyberknife, VMAT and proton therapy based treatment planning.

Baydoun A, Vapiwala N, Ponsky LE, Awan M, Kassaee A, Sutton D, Podder TK, Zhang Y, Dobbins D, Muzic RF Jr, Traughber B, Machtay M, Ellis R.

J Appl Clin Med Phys. 2018 Mar 14. doi: 10.1002/acm2.12308. [Epub ahead of print]


Radiomic features on MRI enable risk categorization of prostate cancer patients on active surveillance: Preliminary findings.

Algohary A, Viswanath S, Shiradkar R, Ghose S, Pahwa S, Moses D, Jambor I, Shnier R, Böhm M, Haynes AM, Brenner P, Delprado W, Thompson J, Pulbrock M, Purysko AS, Verma S, Ponsky L, Stricker P, Madabhushi A.

J Magn Reson Imaging. 2018 Feb 22. doi: 10.1002/jmri.25983. [Epub ahead of print]


Pooled analysis of stereotactic ablative radiotherapy for primary renal cell carcinoma: A report from the International Radiosurgery Oncology Consortium for Kidney (IROCK).

Siva S, Louie AV, Warner A, Muacevic A, Gandhidasan S, Ponsky L, Ellis R, Kaplan I, Mahadevan A, Chu W, Swaminath A, Onishi H, Teh B, Correa RJ, Lo SS, Staehler M.

Cancer. 2018 Mar 1;124(5):934-942. doi: 10.1002/cncr.31156. Epub 2017 Dec 20.


Absorbable Hydrogel Spacer Use in Prostate Radiotherapy: A Comprehensive Review of Phase 3 Clinical Trial Published Data.

Karsh LI, Gross ET, Pieczonka CM, Aliotta PJ, Skomra CJ, Ponsky LE, Nieh PT, Han M, Hamstra DA, Shore ND.

Urology. 2018 May;115:39-44. doi: 10.1016/j.urology.2017.11.016. Epub 2017 Nov 23. Review.


Prostate shapes on pre-treatment MRI between prostate cancer patients who do and do not undergo biochemical recurrence are different: Preliminary Findings.

Ghose S, Shiradkar R, Rusu M, Mitra J, Thawani R, Feldman M, Gupta AC, Purysko AS, Ponsky L, Madabhushi A.

Sci Rep. 2017 Nov 20;7(1):15829. doi: 10.1038/s41598-017-13443-8.


Inflammatory pseudotumor of kidney: a challenging diagnostic entity.

Mukkamala A, Elliott RM, Fulton N, Gulani V, Ponsky LE, Autorino R.

Int Braz J Urol. 2018 Jan-Feb;44(1):196-198. doi: 10.1590/S1677-5538.IBJU.2017.0063. No abstract available.


Cost-effectiveness of MR Imaging-guided Strategies for Detection of Prostate Cancer in Biopsy-Naive Men.

Pahwa S, Schiltz NK, Ponsky LE, Lu Z, Griswold MA, Gulani V.

Radiology. 2017 Oct;285(1):157-166. doi: 10.1148/radiol.2017162181. Epub 2017 May 17.


Development of a Combined MR Fingerprinting and Diffusion Examination for Prostate Cancer.

Yu AC, Badve C, Ponsky LE, Pahwa S, Dastmalchian S, Rogers M, Jiang Y, Margevicius S, Schluchter M, Tabayoyong W, Abouassaly R, McGivney D, Griswold MA, Gulani V.

Radiology. 2017 Jun;283(3):729-738. doi: 10.1148/radiol.2017161599. Epub 2017 Feb 10.


Computational imaging reveals shape differences between normal and malignant prostates on MRI.

Rusu M, Purysko AS, Verma S, Kiechle J, Gollamudi J, Ghose S, Herrmann K, Gulani V, Paspulati R, Ponsky L, Böhm M, Haynes AM, Moses D, Shnier R, Delprado W, Thompson J, Stricker P, Madabhushi A.

Sci Rep. 2017 Feb 1;7:41261. doi: 10.1038/srep41261.


Radiomic features for prostate cancer detection on MRI differ between the transition and peripheral zones: Preliminary findings from a multi-institutional study.

Ginsburg SB, Algohary A, Pahwa S, Gulani V, Ponsky L, Aronen HJ, Boström PJ, Böhm M, Haynes AM, Brenner P, Delprado W, Thompson J, Pulbrock M, Taimen P, Villani R, Stricker P, Rastinehad AR, Jambor I, Madabhushi A.

J Magn Reson Imaging. 2017 Jul;46(1):184-193. doi: 10.1002/jmri.25562. Epub 2016 Dec 19.


Real-time in vivo dosimetry for SBRT prostate treatment using plastic scintillating dosimetry embedded in a rectal balloon: a case study.

Cantley JL, Cheng CW, Jesseph FB, Podder TK, Colussi VC, Traughber BJ, Ponsky LE, Ellis RJ.

J Appl Clin Med Phys. 2016 Nov 8;17(6):305-311. doi: 10.1120/jacmp.v17i6.6508.


Outcomes and toxicities in patients treated with definitive focal therapy for primary prostate cancer: systematic review.

Baydoun A, Traughber B, Morris N, Abi Zeid Daou M, McGraw M, Podder TK, Muzic RF Jr, Lo SS, Ponsky LE, Machtay M, Ellis R.

Future Oncol. 2017 Mar;13(7):649-663. doi: 10.2217/fon-2016-0354. Epub 2016 Nov 4. Review.


AutoStitcher: An Automated Program for Efficient and Robust Reconstruction of Digitized Whole Histological Sections from Tissue Fragments.

Penzias G, Janowczyk A, Singanamalli A, Rusu M, Shih N, Feldman M, Stricker PD, Delprado W, Tiwari S, Böhm M, Haynes AM, Ponsky L, Viswanath S, Madabhushi A.

Sci Rep. 2016 Jul 26;6:29906. doi: 10.1038/srep29906.


Is a behavioral treatment for urinary incontinence beneficial to prostate cancer survivors as a follow-up care?

Zhang AY, Fu AZ, Moore S, Zhu H, Strauss G, Kresevic D, Klein E, Ponsky L, Bodner DR.

J Cancer Surviv. 2017 Feb;11(1):24-31. doi: 10.1007/s11764-016-0557-0. Epub 2016 Jun 24.


Theranostic Agents for Photodynamic Therapy of Prostate Cancer by Targeting Prostate-Specific Membrane Antigen.

Wang X, Tsui B, Ramamurthy G, Zhang P, Meyers J, Kenney ME, Kiechle J, Ponsky L, Basilion JP.

Mol Cancer Ther. 2016 Aug;15(8):1834-44. doi: 10.1158/1535-7163.MCT-15-0722. Epub 2016 Jun 13.


Consensus statement from the International Radiosurgery Oncology Consortium for Kidney for primary renal cell carcinoma.

Siva S, Ellis RJ, Ponsky L, Teh BS, Mahadevan A, Muacevic A, Staehler M, Onishi H, Wersall P, Nomiya T, Lo SS.

Future Oncol. 2016 Mar;12(5):637-45. doi: 10.2217/fon.16.2. Epub 2016 Feb 3.


Stereotactic ablative body radiotherapy for primary kidney cancer: what have we learned from prospective trials and what does the future hold?

Siva S, Daniels CP, Ellis RJ, Ponsky L, Lo SS.

Future Oncol. 2016 Mar;12(5):601-6. doi: 10.2217/fon.16.6. Epub 2016 Feb 3. Review. No abstract available.


Phase I dose-escalation study of stereotactic body radiotherapy (SBRT) for poor surgical candidates with localized renal cell carcinoma.

Ponsky L, Lo SS, Zhang Y, Schluchter M, Liu Y, Patel R, Abouassaly R, Welford S, Gulani V, Haaga JR, Machtay M, Ellis RJ.

Radiother Oncol. 2015 Oct;117(1):183-7. doi: 10.1016/j.radonc.2015.08.030. Epub 2015 Sep 8.


Effects of Patient Centered Interventions on Persistent Urinary Incontinence after Prostate Cancer Treatment: A Randomized, Controlled Trial.

Zhang AY, Bodner DR, Fu AZ, Gunzler DD, Klein E, Kresevic D, Moore S, Ponsky L, Purdum M, Strauss G, Zhu H.

J Urol. 2015 Dec;194(6):1675-81. doi: 10.1016/j.juro.2015.07.090. Epub 2015 Jul 29.


Magnetic resonance imaging for prostate cancer: what the urologist needs to know.

Kiechle J, Pahwa S, Gulani V, Kanaan G, Sedelaar J, Ponsky L.

Minerva Urol Nefrol. 2015 Sep;67(3):201-10. Epub 2015 Jun 9. Review.


Multiattribute probabilistic prostate elastic registration (MAPPER): application to fusion of ultrasound and magnetic resonance imaging.

Sparks R, Bloch BN, Feleppa E, Barratt D, Moses D, Ponsky L, Madabhushi A.

Med Phys. 2015 Mar;42(3):1153-63. doi: 10.1118/1.4905104.


Initial assessment of safety and clinical feasibility of irreversible electroporation in the focal treatment of prostate cancer.

Valerio M, Stricker PD, Ahmed HU, Dickinson L, Ponsky L, Shnier R, Allen C, Emberton M.

Prostate Cancer Prostatic Dis. 2014 Dec;17(4):343-7. doi: 10.1038/pcan.2014.33. Epub 2014 Sep 2.


Does gender influence morbidity or mortality in the surgical treatment of renal masses?

Minnillo BJ, Horowitz A, Finelli A, Alibhai SM, Ponsky LE, Abouassaly R.

Can Urol Assoc J. 2014 May;8(5-6):E311-6. doi: 10.5489/cuaj.1674.


Incidence of hypercoagulable events after image-guided percutaneous cryoablation of renal tumors: a single-center experience.

Hartman JB, Bhojwani N, Corn DJ, Cooney MM, Haaga J, Ponsky L, Abouassaly R, Paspulati A, Prologo JD.

J Vasc Interv Radiol. 2014 May;25(5):776-9. doi: 10.1016/j.jvir.2014.01.027. Epub 2014 Mar 18.


Multiparametric magnetic resonance imaging guided diagnostic biopsy detects significant prostate cancer and could reduce unnecessary biopsies and over detection: a prospective study.

Thompson JE, Moses D, Shnier R, Brenner P, Delprado W, Ponsky L, Pulbrook M, Böhm M, Haynes AM, Hayen A, Stricker PD.

J Urol. 2014 Jul;192(1):67-74. doi: 10.1016/j.juro.2014.01.014. Epub 2014 Feb 8.


The impact of recent screening recommendations on prostate cancer screening in a large health care system.

Aslani A, Minnillo BJ, Johnson B, Cherullo EE, Ponsky LE, Abouassaly R.

J Urol. 2014 Jun;191(6):1737-42. doi: 10.1016/j.juro.2013.12.010. Epub 2013 Dec 14.


Renal radiosurgery: cautious optimism.

Ponsky LE.

Can J Urol. 2013 Oct;20(5):6950. No abstract available.


Pneumodissection: an alternative protective technique for the percutaneous cryoablation of small renal masses.

Maurice MJ, Haaga JR, Nakamoto DA, Ponsky LE.

Urol Int. 2013;90(4):381-3. doi: 10.1159/000346332. Epub 2013 Apr 9.


En bloc transurethral resection of bladder lesions: a trick to retrieve specimens up to 4.5 cm.

Maurice MJ, Ponsky LE.

BJU Int. 2013 Mar;111(3):E15-6. doi: 10.1111/bju.12020_8. No abstract available.


Four-year outcomes of hypofractionated high-dose-rate prostate brachytherapy and external beam radiotherapy.

Chen WC, Tokita KM, Ravera J, Fu P, Jiang Y, Kaminsky DA, Ponsky L, Ellis RJ.

Brachytherapy. 2013 Sep-Oct;12(5):422-7. doi: 10.1016/j.brachy.2012.09.003. Epub 2013 Feb 4.


The true risk of blood transfusion after nephrectomy for renal masses: a population-based study.

Vricella GJ, Finelli A, Alibhai SM, Ponsky LE, Abouassaly R.

BJU Int. 2013 Jun;111(8):1294-300. doi: 10.1111/j.1464-410X.2012.11721.x. Epub 2013 Jan 31.

Supplemental Content

Loading ...
Support Center